Role of Ayurved medication in Fetal Growth restrictio
Phase 2
- Conditions
- Health Condition 1: O365- Maternal care for known or suspected poor fetal growth
- Registration Number
- CTRI/2021/09/036319
- Lead Sponsor
- PARUL AYURVED HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant women having Garbhashosha diagnosed by clinical sign symptoms and ultrasonography
Age group 20 to 35 years
Asymmetrical IUGR
Gestational age between 28 to 34 weeks of primi or multi parity Upto third Gravida
Patient having Hb percentage more than 7 gram percentage
Exclusion Criteria
Pregnancy with PIH
Symmetrical IUGR
Known cases of DAIBETES MELLITIS Gestational DAIBETES MELLITIS Cardiac and Renal Disease Kochs
Twin pregnancy
Congenital malformations of fetus
Patients of Abruption of placenta
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in fetal weight Termination of Pregnancy at TermTimepoint: baseline at 4 weeks 8 weeks and after delivery
- Secondary Outcome Measures
Name Time Method ABSENCE OF MATERNAL COMPLICATIONS LIKE PREVENTION OF POSTPARTUM PHYSCOLOGICAL PROBLEMS HIGH APGAR SCORE PREVENTION OF BIRTH ASPHYXIATimepoint: immediately after delivery